$401.98
0.77% yesterday
NYSE, Feb 04, 10:10 pm CET
ISIN
US0367521038
Symbol
ELV

Elevance Health Stock price

$401.98
+22.33 5.88% 1M
-121.51 23.21% 6M
+33.08 8.97% YTD
-88.35 18.02% 1Y
-44.28 9.92% 3Y
+128.61 47.05% 5Y
+264.33 192.03% 10Y
NYSE, Closing price Tue, Feb 04 2025
-3.12 0.77%
ISIN
US0367521038
Symbol
ELV
Sector

Key metrics

Market capitalization $93.23b
Enterprise Value $116.28b
P/E (TTM) P/E ratio 15.70
EV/FCF (TTM) EV/FCF 25.55
EV/Sales (TTM) EV/Sales 0.66
P/S ratio (TTM) P/S ratio 0.53
P/B ratio (TTM) P/B ratio 2.13
Dividend yield 1.62%
Last dividend (FY24) $6.52
Revenue growth (TTM) Revenue growth 3.19%
Revenue (TTM) Revenue $176.81b
EBIT (operating result TTM) EBIT $8.89b
Free Cash Flow (TTM) Free Cash Flow $4.55b
EPS (TTM) EPS $25.61
P/E forward 12.61
P/S forward 0.49
EV/Sales forward 0.61
Short interest 1.57%
Show more

Is Elevance Health a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

Elevance Health Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a Elevance Health forecast:

17x Buy
71%
6x Hold
25%
1x Sell
4%

Analyst Opinions

24 Analysts have issued a Elevance Health forecast:

Buy
71%
Hold
25%
Sell
4%

Financial data from Elevance Health

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
176,810 176,810
3% 3%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 38,962 38,962
7% 7%
22%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization 1,393 1,393
20% 20%
1%
EBIT (Operating Income) EBIT 8,888 8,888
2% 2%
5%
Net Profit 5,980 5,980
0% 0%
3%

In millions USD.

Don't miss a Thing! We will send you all news about Elevance Health directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Elevance Health Stock News

Neutral
Business Wire
one day ago
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health Foundation today announces its new five-year, $150 million commitment aimed at addressing the physical, behavioral, and social needs of under-resourced communities. Building off the Foundation's momentum from the last three years, this new strategy will strengthen its efforts to create healthier communities through an expanded multi-lever approach ...
Positive
Seeking Alpha
2 days ago
The SPDR S&P 500 ETF Trust starts 2025 on a positive note gaining 2.67% in January. The Top 15 dividend growth stocks for February 2025 offer an average dividend yield of 1.64% and appear to be about 25% undervalued based on dividend yield theory. Since its inception in September 2020, the watch list has achieved a 11.03% compound annual growth rate.
Positive
Market Watch
2 days ago
Trump has pledged to protect Social Security and Medicare throughout his campaign, one analyst noted, but this was the first time he added Medicaid to the list.
More Elevance Health News

Company Profile

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Head office United States
CEO Gail Boudreaux
Founded 1944
Website www.elevancehealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today